Dostinex (Cabergoline) - Summary

DOSTINEX SUMMARY

DOSTINEX^®
cabergoline tablets

DOSTINEX Tablets contain cabergoline, a dopamine receptor agonist.

DOSTINEX Tablets are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.

DOSTINEX NEWS HIGHLIGHTS

Published Studies Related to Dostinex (Cabergoline)

Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. [2007.08]

Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial. [2007.04.15]

Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial. [2007.02.01]

Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study. [2006.11]

Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR). [2006.09.26]

more>>

Clinical Trials Related to Dostinex (Cabergoline)

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions [Completed]

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions [Completed]

Cardiac Valve Complications in Prolactinomas Treated With Cabergoline [Completed]

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease [Completed]

Cabergoline Reduces OHSS [Completed]

more>>